4Hou LJ,Wang HY. Effect of statin therapy on cardiovas- cular and renal outcomes in patients with chronic kidney disease:a systematic review and meta-analysis[J]. Eur Heart, 2013,34(24) : 1807-1817.
5Kujawa-Szewieczek A,Wiecek A, Piecha G. The lipid sto ry in chronic kidney disease: a long story with a happy end? [J]. Int Urol Nephrol,2013,45(5) :1273-1287.
6Kassimatis TI, Goldsmith DJ. Statins in chronic kidney dis ease and kidney transplantation [J]. Pharmacological Re- search,2014(88) :62-73.
7Leoncini M,Toso A,Maioli M,et al. Early high-dose ro- suvastatin for contrast induced nephropathy prevention in acute coronary syndrome: results from the PRATO ACS Study (Protective Effect of Rosuvastatin and Antiplatelet Therapy On contrast induced acute kidney injury and my- ocardial damage[J]. J Am Coil Cardiol, 2014,63 ( 1 ) : 71- 79.
8Han Y, Zhu G, Han L, et al. Short-term rosuvastatin ther apy for prevention of contrast induced acute kidney injury in patients with diabetes and chronic kidney disease[J]. J Am Coil Cardiol,2014,63(1) :62-70.
9Liu Y, Liu YH, Tan N, et al. Comparison of the efficacy of rosuvastatin versus atorvastatin in preventing contrast in &iced nephropathy in patient with chronic kidney disease undergoing percutaneous coronary intervention[J]. PLoS One, 2014,9 (10) : ell 1124.
10Savarese G, Musella F, Volpe M, et al. Effects of atorvas tatin and rosuvastatin on renal function: a meta-analysis [J]. Int J Cardiol,2013,167(6):2482-2489.
